Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and Stock Compensation (Tables)

v3.24.2.u1
Stockholders Equity and Stock Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Summary of Stock Repurchase Activities

The following table provides a summary the Company’s stock repurchase activities:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Shares repurchased

 

 

878,900

 

 

 

579,475

 

 

 

1,873,115

 

 

 

1,255,665

 

Average cost per share

 

$

68.29

 

 

$

51.79

 

 

$

64.08

 

 

$

47.80

 

Total cost of shares repurchased (in thousands)

 

$

60,018

 

 

$

30,012

 

 

$

120,038

 

 

$

60,026

 

 

Summary of Stock-Based Instruments

The Company issued the following stock-based instruments:

 

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

 

Granted

 

 

Weighted-Average Grant-Date Fair Value

 

 

Granted

 

 

Weighted-Average Grant-Date Fair Value

 

Restricted stock

 

 

1,174,060

 

 

$

58.90

 

 

 

885,490

 

 

$

45.83

 

Performance-based restricted stock

 

 

93,500

 

 

$

60.91

 

 

 

121,225

 

 

$

43.34

 

Market-based restricted stock

 

 

93,500

 

 

$

78.80

 

 

 

121,225

 

 

$

59.71

 

Summary of Unvested Shares

A summary of the status and changes of the Company’s unvested shares is presented below:

 


 

 

Shares

 

 

Weighted-Average Grant-Date Fair Value

 

Unvested at December 31, 2023

 

 

3,462,705

 

 

$

43.54

 

Granted

 

 

1,361,060

 

 

 

60.40

 

Vested

 

 

(1,813,331

)

 

 

42.85

 

Cancelled

 

 

(25,850

)

 

 

49.53

 

Performance Adjustment

 

 

224,809

 

 

 

46.87

 

Unvested at June 30, 2024

 

 

3,209,393

 

 

$

51.26

 

Summary of the Payout for EPS and TSR Grants

A summary of the payout for EPS and TSR grants is presented below:

 

 

Six Months Ended June 30, 2024

 

 

 

Target Shares

 

 

Payout Factor

 

 

Performance Adjustment

 

December 2020 EPS Grant

 

 

125,000

 

 

 

133

%

 

 

41,665

 

December 2020 TSR Grant

 

 

125,000

 

 

 

162

%

 

 

77,250

 

March 2021 EPS Grant

 

 

108,750

 

 

 

133

%

 

 

36,250

 

March 2021 TSR Grant

 

 

108,750

 

 

 

164

%

 

 

69,644

 

Total Performance Adjustments

 

 

 

 

 

 

 

 

224,809